[{"title": "Enabling FAIR data stewardship in complex international multi-site studies: Data Operations for the Accelerating Medicines Partnership\u00ae Schizophrenia Program", "link": "https://www.nature.com/articles/s41537-025-00560-x", "details": "T Billah, KIK Cho, O Borders, Y Chung, M Ennis\u2026 - Schizophrenia, 2025", "abstract": "Modern research management, particularly for publicly funded studies, assumes a data governance model in which grantees are considered stewards rather than owners of important data sets. Thus, there is an expectation that collected data are \u2026"}, {"title": "Evaluating the Performance of Large Language Models in Identifying Human Facial Emotions: GPT 4o, Gemini 2.0 Experimental, and Claude 3.5 Sonnet", "link": "https://osf.io/pxq5h_v1/download", "details": "B Nelson, A Winbush, S Siddals, J Torous, N Allen\u2026 - 2025", "abstract": "Background. Evaluating the social and emotional capabilities of large language models (LLMs), such as their ability to recognize human facial emotion is critical as their role in human-computer interactions (HCIs) expands, particularly in healthcare \u2026"}, {"title": "Data analysis strategies for the Accelerating Medicines Partnership\u00ae Schizophrenia Program", "link": "https://www.nature.com/articles/s41537-025-00561-w", "details": "N Penzel, P Polosecki, J Addington, C Arango\u2026 - Schizophrenia, 2025", "abstract": "Abstract The Accelerating Medicines Partnership\u00ae Schizophrenia (AMP\u00ae SCZ) project assesses a large sample of individuals at clinical high-risk for developing psychosis (CHR) and community controls. Subjects are enrolled in 43 sites across 5 \u2026"}]
